View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
January 13, 2022

Magazine: Tackling telemedicine fraud

In this issue: How fraudsters are gaming the US healthcare system, regulating the grey area between drugs and devices, and more.

By Susanne Hauner

The latest issue of Medical Technology magazine is out now. Read it for free online on all devices.

Ongoing investigations in the US have revealed telemedicine’s vulnerability to fraudulent activity, with the recent Operation ‘Happy Clickers’ targeting fraud losses of more than $7m. We find out how fraudsters are gaming the US healthcare system under the guise of telemedicine and what can be done about it.

Last year, a court told the FDA it had wrongly classified a device as a drug, raising questions about how medicines and devices are defined by the agency. In this issue, we explore which products fall into the grey area between drugs and devices and the financial and regulatory consequences for companies whose products are moved from one category to another.

Also in this issue, we speak to XIL Health founder and CEO Susan Lang about the future potential of 3D printed drugs. We hear why Lang believes 3D printing in drug manufacturing could revolutionise personalised medicine, democratise access to medicines, improve sustainability in the supply chain and speed up the response time when infectious diseases spread.

Read the latest issue of Medical Technology  for all this as well as the latest news, comment and data from GlobalData.

You can also subscribe here to receive email notifications when a new issue is available.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU